In the 12 months following Maryland’s cannabis legalisation, dispensaries reported over $1 billion in sales, a figure that advocates herald as economic progress. However, beneath the gleaming storefronts and rising tax revenues lies a troubling reality that communities across the state are beginning to confront.

Josue Sierra, a Maryland Family Institute consultant and long-time Cecil County resident, has raised alarm bells about the genuine marijuana legalisation impact on local communities. His concerns centre on public health consequences that are often overshadowed by the industry’s marketing narrative.

The Potency Problem

Today’s cannabis products bear little resemblance to marijuana from previous decades. Modern dispensaries stock high-THC concentrates that are three to five times stronger than products available a generation ago. This significant increase in potency has transformed the conversation around legalised marijuana entirely.

“The truth is, legalised marijuana is no gift to our community,” Sierra argues, pointing to mounting evidence of serious mental health consequences, particularly amongst young adults who have normalised frequent, high-dose consumption.

Research demonstrates that states embracing legalised cannabis experience sharp increases in daily or near-daily use, the strongest predictor of dependency. What advocates frame as therapeutic use often masks a pattern of self-medication with potentially addictive substances.

Medical Programme Concerns

Even regulated medical marijuana programmes face significant oversight challenges. Recent investigations into Pennsylvania’s medical cannabis system revealed thousands of certifications approved with minimal scrutiny. State officials admitted lacking the authority to properly audit the programme, raising questions about the cannabis legalisation effects on regulatory frameworks.

Users themselves report developing psychological dependencies, struggling with basic functions without cannabis use. These warnings, however, remain buried beneath industry messaging promoting variety and safety.

The Black Market Myth

One of the central promises of legalised marijuana was eliminating illegal drug markets. Reality tells a different story. Legal and illegal cannabis economies now operate in parallel, with unlicensed dealers maintaining substantial market share.

California’s experience proves instructive. Despite being amongst the most established legal markets, a 2024 RAND report found that over 60% of cannabis sold in the state still moves through unlicensed channels. The marijuana legalisation impact on black market elimination has fallen far short of promises. Maryland’s recent decision to increase taxes on adult-use cannabis from 9% to 12% will likely push even more consumers towards illegal suppliers.

Economic Reality Check

Maryland collected $73 million in cannabis-related tax revenue last year, a figure that pales against long-term community costs. Marijuana-impaired driving incidents have increased, whilst emergency room visits for cannabis-related psychosis and anxiety have spiked in other states with legalised marijuana.

The social costs (increased addiction rates, workplace accidents, reduced productivity, and strain on schools and law enforcement) rarely feature in economic calculations. These cannabis legalisation effects extend far beyond simple revenue figures. More troubling still, only 5% of tax revenue reaches county level, leaving schools, drug treatment centres, and mental health services without resources to address emerging problems.

Cecil County, home to two dispensaries, exemplifies these challenges. Communities face the consequences of policies seemingly driven more by profit margins than public health considerations.

Youth at Risk

Perhaps most concerning is the marijuana legalisation impact on young people. Normalised consumption amongst demographics particularly vulnerable to addiction and mental health complications presents serious risks. High-potency products marketed in attractive packaging create an environment where experimental use can quickly escalate to dependency.

Public health experts stress that adolescent and young adult brains remain in crucial development stages, making them especially susceptible to the neurological impacts of regular cannabis use. The long-term consequences of normalising high-THC product consumption in this demographic remain inadequately studied.

A Call for Reassessment

Sierra argues that whilst not everyone purchasing cannabis products struggles with addiction, effective policy must address patterns and consequences rather than anecdotal exceptions. The patterns emerging from Maryland’s experience with legalised marijuana suggest serious cause for concern.

“Legal cannabis may be here,” Sierra acknowledges, “but that doesn’t mean it’s helping us.” He calls on Maryland lawmakers from both parties to critically examine the industry’s claims and consider the genuine marijuana legalisation impact on families, youth, and community wellbeing.

The question facing Maryland and other jurisdictions considering cannabis legalisation is whether short-term tax revenues justify the mounting public health costs. As evidence accumulates, the case for reassessing legalisation policies grows stronger.

Communities deserve policies based on comprehensive health data rather than industry marketing. Understanding the full cannabis legalisation effects requires looking beyond revenue figures. The billion-dollar sales figures may impress shareholders, but they tell only part of the story. The other part, written in emergency room visits, addiction treatment admissions, and families struggling with dependency, demands equal attention from policymakers.

Source: Baltimore Sun